Business Description
GlucoTrack Inc
NAICS : 339112
SIC : 3841
ISIN : US45824Q1013
Description
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | -4.87 | |||||
| Debt-to-Equity | -0.56 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -18.6 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | -10.3 | |||||
| 3-Year Book Growth Rate | -35.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.61 | |||||
| 9-Day RSI | 19.82 | |||||
| 14-Day RSI | 21.78 | |||||
| 6-1 Month Momentum % | -25 | |||||
| 12-1 Month Momentum % | 20 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.14 | |||||
| Quick Ratio | 0.14 | |||||
| Cash Ratio | 0.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.6 | |||||
| Shareholder Yield % | -28.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -4099.78 | |||||
| ROA % | -476.82 | |||||
| ROIC % | -1169.28 | |||||
| ROC (Joel Greenblatt) % | -12275.28 | |||||
| ROCE % | -2244.09 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.3 | |||||
| EV-to-EBITDA | -0.3 | |||||
| EV-to-FCF | -0.34 | |||||
| Earnings Yield (Greenblatt) % | -333.33 | |||||
| FCF Yield % | -580.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GCTK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlucoTrack Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.85 | ||
| Beta | 0.58 | ||
| Volatility % | 180.96 | ||
| 14-Day RSI | 21.78 | ||
| 14-Day ATR ($) | 0.161997 | ||
| 20-Day SMA ($) | 0.64656 | ||
| 12-1 Month Momentum % | 20 | ||
| 52-Week Range ($) | 0.216 - 4.95 | ||
| Shares Outstanding (Mil) | 8.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlucoTrack Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlucoTrack Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GlucoTrack Inc Frequently Asked Questions
What is GlucoTrack Inc(GCTK)'s stock price today?
The current price of GCTK is $0.24. The 52 week high of GCTK is $4.95 and 52 week low is $0.22.
When is next earnings date of GlucoTrack Inc(GCTK)?
The next earnings date of GlucoTrack Inc(GCTK) is 2025-02-14 Est..
Does GlucoTrack Inc(GCTK) pay dividends? If so, how much?
GlucoTrack Inc(GCTK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers